SCHEMBL4107398

SCHEMBL4107398

Cc1cc(Nc2ccc(F)cc2)n2ncnc2n1

nearest known ligand 0.80

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.80
▸ KMT2A Q03164 3/20 0.80
▸ MAPK1 P28482 4/20 0.74
▸ ALOX15 P16050 1/20 0.74
▸ TSHR P16473 1/20 0.74
▸ ALDH1A1 P00352 2/20 0.72
▸ HIF1A Q16665 1/20 0.68
▸ GAA P10253 1/20 0.67
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ KDM1A O60341 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4104295 0.89 MEN1 (1.00) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4101327 0.87 MEN1 (0.68) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4108561 0.86 MAPK1 (0.83) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL13769182 0.86 MEN1 (0.80) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4105140 0.86 MEN1 (0.80) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL13730228 0.86 MEN1 (0.80) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4090635 0.86 MEN1 (0.80) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL18118625 0.86 MEN1 (0.79) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4103427 0.85 TSHR (0.70) MEN1KMT2AMAPK1ALOX15TSHR
SCHEMBL4104268 0.85 MAPK1 (0.81) MEN1KMT2AMAPK1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024733-B2 Bio-assisted process for conversion of carbon dioxide to fuel precursors INDIAN OIL CORPORATION LIMITED (IN) 2024-07-02 — — US disclosed
US-9216983-B2 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2015-12-22 — — US disclosed
US-9216983-B2 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2015-12-22 — — US disclosed
US-9216983-B2 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2015-12-22 — — US disclosed
US-20090209557-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM UNIVERSITY OF WASHINGTON 2009-08-20 — — US disclosed
US-20090209557-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM UNIVERSITY OF WASHINGTON 2009-08-20 — — US disclosed
US-20090209557-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM UNIVERSITY OF WASHINGTON 2009-08-20 — — US disclosed
WO-2009082691-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2009-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209557-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY DHODH, DHFR, G6PD MEN1 2788/4885KMT2A 2258/4885MAPK1 3480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback